Cooperative Agreement U01EY037213
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system tailored for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The $305,000 project, awarded on September 1, 2025, with an expected completion date of August 31, 2026, has two key objectives: Develop and optimize a portable AO-OCT system with enhanced imaging capabilities...
- This is a Cooperative Agreement award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research federal grant program (CFDA 93.867). The $791,994 award, which began on September 1, 2025, supports the development of a next-generation ophthalmic microscope with integrated optical coherence tomography (OCT) imaging capabilities. The project aims to overcome limitations of current ophthalmic surgery microscopes by enabling more...
- The National Institute on Aging (NIA) awarded a $397,902 Project Grant to Panluminate Inc., a woman-owned small business in Connecticut, to develop FLASH-PULSE, an automated and multiplexed imaging solution for rapidly mapping the distribution of specific cell markers within tissue samples at the subcellular scale. The project aims to create a microfluidics-based system and novel probes to enable 32-plex protein imaging of formalin-fixed paraffin-embedded (FFPE) tissue samples without the need...
- This federal Project Grant award of $598,108 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of innovative ophthalmic imaging technologies and novel objective, quantifiable functional biomarkers for cone photoreceptors. The primary aims are to: 1) Develop next-generation optical coherence tomography (OCT) technologies to enable functional photoreceptor imaging over a wide retinal area and at high topographical resolution; and 2) Develop novel objective,...
- The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $331,131 Project Grant under the Vision Research program (CFDA 93.867) to Physical Sciences Inc. (PSI) to develop and validate a high-resolution retinal imaging system with light flicker capabilities. This system aims to enable objective characterization of the photoreceptor response to light and quantify differences between normal and diseased eyes, particularly for patients with diabetic retinopathy. PSI,...
- This SBIR Phase I Project Grant, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $304,998 to support the development of a novel visible-light phase shifter and intraocular lens to improve vision for those with age-related macular degeneration. The project aims to create an energy-efficient, small-form factor optical phased array in an implantable intraocular device capable of electronically adjusting and shifting...
- This federal Project Grant award of $315,825.00 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of a new, non-invasive, remote photonic technology for intraocular pressure (IOP) biomonitoring in glaucoma patients. The technology, called Photonic IOP Biomonitoring (PIB), uses sound waves and laser speckle pattern monitoring to deduce IOP without the need for physical eye contact or clinician interpretation. The goal is to miniaturize PIB into monoculars or...
- This $437,250 Project Grant award from the National Eye Institute's Vision Research federal grant program (CFDA 93.867) aims to develop an integrated platform that combines 3D bioprinting, optogenetic stimulation, multi-electrode array (MEA) recording, and real-time fluorescence imaging to create a "visual-circuit-on-a-chip" for evaluating neural activity in stem cell-derived retinal disease models. The project, awarded to the University of California, San Diego, seeks to address...
- The National Eye Institute (NEI) awarded Kineolabs, Inc. a $300,001 Project Grant under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. The objective is to use this LS-SS-OCT technology for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The project aims to make OCT imaging more affordable and accessible to reduce the...
- The National Eye Institute (NEI) awarded a $673,747 Project Grant to New York University (NYU) for the "Visible-to-Near-Infrared Spanning Optical Coherence Tomography for Retinal Imaging at the Half-Micron Scale" research project under the NEI's Vision Research program (CFDA 93.867). The grant aims to develop advanced optical coherence tomography (OCT) techniques to enable more accurate in vivo measurement and localization of macular pigments and retinal pigment epithelium melanosomes,...
This Cooperative Agreement award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $583,247 to Panluminate Inc., a woman-owned small business, to develop a novel microscopy technology called Pan-Optix. The Pan-Optix system combines two advanced imaging techniques, Pan-Expansion Microscopy (Pan-EXM) and FLASH-PAINT, to enable multi-scale, 3D mapping of molecular markers in retinal tissue at the cellular and ultrastructural level. The project aims to (1) validate the Pan-EXM protocol for use with DNA-conjugated antibodies, (2) develop new FLASH-PAINT probes compatible with expanded samples, (3) build an automated light sheet microscope for imaging Pan-Optix samples, and (4) characterize the molecular and ultrastructural heterogeneity of the mouse retina. The award period runs from September 1, 2025 to April 30, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $583.2k | 8/11/25 |